Eli Van Allen

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Eli Van Allen
Apr 26, 2025, 15:35 | Blog
Elizabeth McKenna highlights Eli Van Allen's review on artificial intelligence in oncology
Elizabeth McKenna, Executive Director of Cancer Discovery at the American Association for Cancer Research, shared…
Jan 10, 2025, 22:28 | Science
Chris Labaki: Exploring immunogenomic determinants of exceptional response to ICI in ccRCC
Chris Labaki, Research Associate at Dana-Farber Cancer Institute, shared a post on X about a…
Oct 28, 2024, 09:37 | Insight
Anant Madabhushi: Ten challenges and opportunities in computational immuno-oncology
Anant Madabhushi, Founding director of the Emory Empathetic AI for Health Institute, shared a post…
Oct 9, 2024, 14:32 | Career
Toni Choueiri: Extremely well-deserved honor for Eli Van Allen on his Chair
Toni Choueiri shared a post about Eli Van Allen. Read his post on X below:…
Oct 7, 2024, 17:05 | Blog
CRISPR-based mouse model for VHL-deficient clear cell kidney cancer shows promise, suggested by Yüksel Ürün
Yüksel Ürün shared an article by Laura A Stransky on X: "A new CRISPR-based mouse…
May 26, 2024, 06:02 | Insight
Toni Choueiri: The work of Eddy Saad, Eli Van Allen, Sasha Gusev being highlighted here at ASCO24
Toni Choueiri shared a post by Neeraj Agarwal on X/Twitter: "The work of Eddy Saad, Eli Van…
Apr 10, 2024, 05:06 | Insight
Toni Choueiri: The Renee Saliby kidney cancer biomarker paper in Cancer Cell is online with a detailed tweetorial
Toni Choueiri shared a post by Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber…
Apr 8, 2024, 22:02 | Insight
Renee Maria Saliby: Our paper 'Impact of RCC molecular subtypes on immunotherapy and targeted therapy outcomes' is now published in Cancer Cell
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Sep 20, 2023, 18:14 | Insight
A potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC)- Dana-Farber News.
Quoting Dana-Farber News on X/Twitter: "Eli Van Allen, Jackson Nyman (Dana-Farber Cancer Institute) and Toni…
All: 9 Posts: 1 - 100
Special Coverage